HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in children.

HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in children.
复制标题

DOI:
10.1038/clpt.2013.55
复制
发表时间:
2013-07
影响因子:
6.7
通讯作者:
--
中科院分区:
医学2区
文献类型:
--
作者:

文献摘要

参考文献

被引文献

相似文献

包括罕见但危及生命的史蒂文斯-约翰逊综合征(SJS)和药物性超敏反应综合征(HSS)在内的超敏反应的发生限制了抗惊厥药卡马西平(CBZ)的使用。HLA-B*15:02和HLA-A*31:01已被确定为亚洲和欧洲患者CBZ超敏反应的预测性遗传标记。为了在北美不同种族背景的儿童患者中复制这些遗传关联,我们研究了来自加拿大各地的42名CBZ超敏儿童和91名CBZ耐受儿童的HLA-A*31:01和HLA-B*15:02。HLA-A*31:01与CBZ-HSS(比值比(OR): 26.4, p=0.0025)和黄斑丘疹(OR: 8.6, p=0.0037)显著相关,与CBZ-SJS无显著相关性。相反,HLA-B*15:02与CBZ-SJS相关(OR: 38.6, p=0.002),但与HSS和黄斑丘疹无关。这项研究首次证明了HLA-A*31:01与儿童CBZ超敏反应的关联,提供了这种关联的重要复制,并强调了HLA-A*31:01作为各种祖先的预测性生物标志物的重要性。
The occurrence of hypersensitivity reactions including rare but life-threatening Stevens-Johnson syndrome (SJS) and drug-induced hypersensitivity syndrome (HSS) limits the use of the anticonvulsant carbamazepine (CBZ). HLA-B*15:02 and HLA-A*31:01 have been identified as predictive genetic markers for CBZ hypersensitivity in Asian and European patients. To replicate these genetic associations in pediatric patients from North America with a diverse ethnic background, we investigated HLA-A*31:01 and HLA-B*15:02 in 42 children with CBZ hypersensitivity, and 91 CBZ-tolerant children from across Canada. HLA-A*31:01 was significantly associated with CBZ-HSS (odds ratio (OR): 26.4, p=0.0025) and maculopapular exanthems (OR: 8.6, p=0.0037), but not with CBZ-SJS. Conversely, HLA-B*15:02 was associated with CBZ-SJS (OR: 38.6, p=0.002), but not HSS and maculopapular exanthems. This study is the first to demonstrate the association of HLA-A*31:01 with CBZ hypersensitivity in children, providing important replication of this association and highlighting the importance of HLA-A*31:01 as a predictive biomarker across various ancestries.
DOI: 10.1016/s0140-6736(07)60460-7
发表时间: 2007-03-24
期刊: LANCET
影响因子: 168.9
作者:
Marson, Anthony G.;Al-Kharusi, Asya M.;Alwaidh, Muna;Appleton, Richard;Baker, Gus A.;Chadwick, David W.;Cramp, Celia;Cockerell, Oliver C.;Cooper, Paul N.;Doughty, Julie;Eaton, Barbara;Gamble, Carrot;Goulding, Peter J.;Howell, Stephen J. L.;Hughes, Adrian;Jackson, Margaret;Jacoby, Ann;Kellett, Mark;Lawson, Geoffrey R.;Leach, John Paul;Nicolaides, Paola;Roberts, Richard;Shackley, Phil;Shen, Jing;Smith, David F.;Smith, Philip E. M.;Smith, Catrin Tudur;Vanoli, Alessandra;Williamson, Paula R.
通讯作者: Williamson, Paula R.
DOI: 10.1056/nejmoa1009717
发表时间: 2011-03-24
影响因子: 158.5
作者:
Chen, Pei;Lin, Juei-Jueng;Shen, Chen-Yang
通讯作者: Shen, Chen-Yang
DOI: 10.1007/bf01954091
发表时间: 1993-07-01
影响因子: 3.6
作者:
KONISHI, T;NAGANUMA, Y;OKADA, T
通讯作者: OKADA, T
DOI: 10.1542/peds.2008-1923
发表时间: 2009-02-01
期刊: PEDIATRICS
影响因子: 8
作者:
Levi, Natacha;Bastuji-Garin, Sylvie;Maison, Patrick
通讯作者: Maison, Patrick
DOI: 10.1016/j.eplepsyres.2011.08.010
发表时间: 2011-11-01
期刊: EPILEPSY RESEARCH
影响因子: 2.2
作者:
Kim, Sae-Hoon;Lee, Kyung Wha;Chang, Yoon-Seok
通讯作者: Chang, Yoon-Seok